|F0GBR06R8K -- India Fund|| |
INR 118.03 7.14 5.70%
The entity has beta of -0.1392 which indicates as returns on market increase, returns on owning SBI Pharma are expected to decrease at a much smaller rate. During bear market, SBI Pharma is likely to outperform the market.. Although it is extremely important to respect SBI Pharma Reg
current price movements, it is better to be realistic regarding the information on equity historical returns. The way of measuring future performance of any fund is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators
. By analyzing SBI Pharma Reg technical indicators
you can today evaluate if the expected return of 0.0% will be sustainable into the future.